Cytokines et auto-immunité

Aguayo, 1988, Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-induced HLA-DR expression, J. Clin. Endocrinol. Metab., 66, 903, 10.1210/jcem-66-5-903 Aichinger, 1985, In situ immune complexes, lymphocyte subpopulations and HLA-DR-positive epithelial cells in Hashimoto thyroiditis, Lab. Invest., 52, 132 Ajjan, 1996, Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis, Clin. Exp. Immunol., 105, 523, 10.1046/j.1365-2249.1996.d01-784.x Ajjan, 1997, Detection of IL-12, IL-13 and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease, J. Clin. Endocrinol. Metab., 82, 666, 10.1210/jc.82.2.666 Alimi, 1998, Experimental autoimmune thyroiditis (TAE) in mice lacking the IFN-g receptor gene, Eur. J. Immunol., 28, 201, 10.1002/(SICI)1521-4141(199801)28:01<201::AID-IMMU201>3.0.CO;2-N Allen, 1993, Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis, J. Immunol., 151, 4344, 10.4049/jimmunol.151.8.4344 Allison, 1992, Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta cells, Eur. J. Immunol., 22, 1115, 10.1002/eji.1830220503 Amrani, 1996, Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage, J. Endocrinol., 148, 139, 10.1677/joe.0.1480139 Ando, 1989, Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype, Cell. Immunol., 124, 132, 10.1016/0008-8749(89)90117-2 Andre, 1996, Checkpoints in the progression of autoimmune disease: lessons from diabetes models, 93, 2260 Aust, 1996, Expression of tumour necrosis factor-α (TNF-a) mRNA and protein in pathological thyroid tissue and carcinoma cell lines, Clin. Exp. Immunol., 105, 148, 10.1046/j.1365-2249.1996.d01-726.x Balashov, 1997, Increased interleukin-12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand, 94, 599 Bandara, 1993, Intra-articular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer, 90, 10764 Barton, 1995, The kinetics of cytokine mRNA expression in the retina during experimental autoimmune uveoretinitis, Cell Immunol., 164, 133, 10.1006/cimm.1995.1152 Bauer, 1993, Demonstration of interleukin-1 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level, J. Neuroimmunol., 48, 13, 10.1016/0165-5728(93)90053-2 Bendelac, 1987, Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells, J. Exp. Med., 166, 823, 10.1084/jem.166.4.823 Berman, 1996, Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus, J. Immunol., 157, 4690, 10.4049/jimmunol.157.10.4690 Bernard, 1992, High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice, Diabetes, 41, 40, 10.2337/diabetes.41.1.40 Bessis, 1996, Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13, Eur. J. Immunol., 26, 2399, 10.1002/eji.1830261020 Bessis, 1998, Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF alpha) -transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13, Clin. Exp. Immunol., 111, 391, 10.1046/j.1365-2249.1998.00500.x Billiau, 1988, Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma, J. Immunol., 140, 1506, 10.4049/jimmunol.140.5.1506 Boissier, 1995, Biphasic effect of interferon-γ in murine collagen-induced arthritis, Eur. J. Immunol., 25, 1184, 10.1002/eji.1830250508 Bottazzo, 1983, Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity, Lancet, 2, 1115, 10.1016/S0140-6736(83)90629-3 Brabb, 1997, Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis, J. Immunol., 159, 497, 10.4049/jimmunol.159.1.497 Braley-Mullen, 1985, Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells, Cell Immunol., 93, 132, 10.1016/0008-8749(85)90394-6 Braley-Mullen, 1991, Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody, J. Exp. Med., 173, 899, 10.1084/jem.173.4.899 Briolay, 1992, Interleukin-4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients, J. Clin. Immunol., 12, 36, 10.1007/BF00918271 Campbell, 1988, IFN-γ and TNF-α. Cytotoxicity to murine islets of Langerhans, J. Immunol., 141, 2325, 10.4049/jimmunol.141.7.2325 Cash, 1994, Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats, J. Immunol., 153, 4258, 10.4049/jimmunol.153.9.4258 Caspi, 1994, Endogenous systemic IFN-g has a protective role against ocular autoimmunity in mice, J. Immunol., 152, 890, 10.4049/jimmunol.152.2.890 Cearns-Spielman, 1990, Interferon-g increases susceptibility of murine pancreatic b cells to lysis by allogeneic cytotoxic T lymphocytes, Autoimmunity, 8, 135, 10.3109/08916939008995731 Charreire, 1989, Immune mechanisms in autoimmune thyroiditis, Adv. Immunol., 46, 263, 10.1016/S0065-2776(08)60656-2 Chomarat, 1995, Balance of IL-1 receptor antagonist/IL-1 b in rheumatoid synovium and its regulation by IL-4 and IL-10, J. Immunol., 154, 1432, 10.4049/jimmunol.154.3.1432 Chronopoulou, 1992, Identification of a thyroiditogenic sequence within the thyroglobulin molecule, J. Immunol., 149, 1039, 10.4049/jimmunol.149.3.1039 Chu, 1991, Localization of TNF-a in synovial tissues and at the cartilagepannus junction in patients with rheumatoid arthritis, Arthritis Rheum., 34, 1125, 10.1002/art.1780340908 Cohen, 1995, High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane, Arthritis Rheum., 38, 946, 10.1002/art.1780380710 Conaway, 1990, In situ analysis of T cell subset composition in experimental autoimmune thyroiditis after adoptive transfer of activated spleen cells, Cell. Immunol., 125, 247, 10.1016/0008-8749(90)90078-6 Cooper, 1988, Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ, J. Immunol., 141, 1958, 10.4049/jimmunol.141.6.1958 Cooper, 1992, Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-β, Clin. Exp. Immunol., 89, 244, 10.1111/j.1365-2249.1992.tb06939.x Cua, 1995, Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE) -resistant mice. Th2-mediated suppression of autoimmune disease, J. Immunol., 155, 4052, 10.4049/jimmunol.155.8.4052 Cush, 1995, Elevated interleukin-10 levels in patients with rheumatoid arthritis, Arthritis Rheum., 38, 96, 10.1002/art.1780380115 Damotte, 1997, Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis, Eur. J. Immunol., 27, 2854, 10.1002/eji.1830271117 De Kozak, 1994, Differential tumor necrosis factor expression by resident retinal cells from experimental uveitis-susceptible and -resistant rat strains, J. Neuroimmunol., 55, 1, 10.1016/0165-5728(94)90141-4 Dechanet, 1993, IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle, J. Immunol., 151, 4908, 10.4049/jimmunol.151.9.4908 Dick, 1996, Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina, Eur. J. Immunol., 26, 1018, 10.1002/eji.1830260510 Drulovic, 1997, Interleukin-12 and tumor necrosis factor-a levels in cerebrospinal fluid of multiple sclerosis patients, J. Neurol. Sci., 147, 145, 10.1016/S0022-510X(96)05320-8 Evans, 1996, Clinical trial to assess the safety, feasibility and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis, Hum. Gene Ther., 7, 1261, 10.1089/hum.1996.7.10-1261 Fabry, 1995, TGF-β 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo, J. Immunol., 155, 325, 10.4049/jimmunol.155.1.325 Falcone, 1997, A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis, J. Exp. Med., 185, 901, 10.1084/jem.185.5.901 Ferber, 1996, Mice with a disrupted IFN-g gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE), J. Immunol., 156, 5, 10.4049/jimmunol.156.1.5 Ferrante, 1998, Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM) -expressing lymphocytes in acute multiple sclerosis, J. Immunol., 160, 1514, 10.4049/jimmunol.160.3.1514 Fiette, 1995, Theiler's virus infection of 129Sv mice that lack the Interferon alpha/beta or interferon gamma receptors, J. Exp. Med., 181, 2069, 10.1084/jem.181.6.2069 Firestein, 1990, Quantitative analysis of cytokine gene expression in rheumatoid arthritis, J. Immunol., 144, 3347, 10.4049/jimmunol.144.9.3347 Geiger, 1994, Transgenic mice expressing IFN-γ in the retina develop inflammation of the eye and photoreceptor loss, Invest. Ophthalmol. Vis. Sci., 35, 2667 Giordano, 1997, Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis, Science, 275, 960, 10.1126/science.275.5302.960 Grewal, 1996, Local expression of transgene encoded TNF-α in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells, J. Exp. Med., 184, 1963, 10.1084/jem.184.5.1963 Grubeck-Loebenstein, 1989, Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6, Clin. Exp. Immunol., 77, 324 Hanafusa, 1983, Aberrant expression of HLA-DR antigen on thyrocytes in Graves'disease: relevance for autoimmunity, Lancet, 2, 1111, 10.1016/S0140-6736(83)90628-1 Hayashi, 1996, Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis, Graefes Arch. Clin. Exp. Ophthalmol., 234, 633, 10.1007/BF00185297 Heath, 1992, Autoimmune diabetes as a consequence of locally produced interleukin-2, Nature, 359, 547, 10.1038/359547a0 Hoey, 1997, Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-γ dependent mechanism, J. Immunol., 159, 5132, 10.4049/jimmunol.159.10.5132 Horn, 1988, In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice, J. Immunol., 141, 834, 10.4049/jimmunol.141.3.834 Hooks, 1988, Identification of the lymphokines, interferon-g interleukin-2, in inflammatory eye diseases, Invest. Ophthalmol. Vis. Sci., 29, 1444 Horwitz, 1997, Primary demyelination in transgenic mice expressing interferon-γ, Nat. Med., 3, 1037, 10.1038/nm0997-1037 Huang, 1993, Immune response in mice that lack the interferon-γ receptor, Science, 259, 1742, 10.1126/science.8456301 Hultgren, 1996, Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice, Diabetes, 45, 812, 10.2337/diabetes.45.6.812 Hung, 1994, Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium, Gene Ther., 1, 64 Hussain, 1996, Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM, Diabetologia, 39, 60, 10.1007/BF00400414 Inobe, 1996, In vivo administration of IL-4 induces TGF-β producing cells and protects animals from experimental autoimmune encephalomyelitis, Ann. N. Y. Acad. Sci., 778, 390, 10.1111/j.1749-6632.1996.tb21153.x Issazadeh, 1995, Interferon-γ, interleukin-4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells, J. Neurosci. Res., 40, 579, 10.1002/jnr.490400503 Jacob, 1989, Heterogeneous effects of IFN-γ in adjuvant arthritis, J. Immunol., 142, 1500, 10.4049/jimmunol.142.5.1500 Johns, 1993, Experimental allergic encephalomyelitis: neutralizing antibody to TGF-b 1 enhances the clinical severity of the disease, J. Neuroimmunol., 47, 1, 10.1016/0165-5728(93)90278-7 Jones, 1997, IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response, J. Immunol., 158, 5997, 10.4049/jimmunol.158.12.5997 Joosten, 1997, Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction, Arthritis Rheum., 40, 249, 10.1002/art.1780400209 Kalimann, 1997, Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves'disease, Diabetes, 46, 237, 10.2337/diabetes.46.2.237 Kamijo, 1993, Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon-γ receptor, 90, 6626 Katsikis, 1994, Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J. Exp. Med., 179, 1517, 10.1084/jem.179.5.1517 Katz, 1995, T helper cell subsets in insulin-dependent diabetes, Science, 268, 1185, 10.1126/science.7761837 Keffer, 1991, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J., 10, 4025, 10.1002/j.1460-2075.1991.tb04978.x Kelley, 1988, Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis, J. Immunol., 140, 59, 10.4049/jimmunol.140.1.59 Kennedy, 1992, Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery, J. Immunol., 149, 2496, 10.4049/jimmunol.149.7.2496 Khoruts, 1995, Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells, J. Immunol., 155, 5011, 10.4049/jimmunol.155.10.5011 Khoury, 1991, Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction, Am. J. Pathol., 138, 1209 Krakowski, 1996, Interferongamma confers resistance to experimental allergic encephalomyelitis, Eur. J. Immunol., 26, 1641, 10.1002/eji.1830260735 Kromer, 1987, Mechanisms of T cell hyperreactivity in obese strain (OS) chickens with spontaneous autoimmune thyroiditis: lack in nonspecific suppression is due to a primary adherent cell defect, J. Immunol., 138, 2104, 10.4049/jimmunol.138.7.2104 Lafaille, 1997, Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease, J. Exp. Med., 186, 307, 10.1084/jem.186.2.307 Lee, 1994, Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction, J. Clin. Invest., 93, 1332, 10.1172/JCI117092 Liblau, 1995, Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases, Immunol. Today, 16, 34, 10.1016/0167-5699(95)80068-9 Lombardi, 1997, Antigen presentation by interferon-γ treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells, Eur. J. Immunol., 27, 62, 10.1002/eji.1830270110 Londei, 1984, Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells, Nature, 312, 639, 10.1038/312639a0 Lühder, 1998, Cytotoxic T lymphocyte associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes, J. Exp. Med., 187, 427, 10.1084/jem.187.3.427 Luna, 1997, Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, TNF-α and interleukin-1 β-mediated breakdown, J. Neurosci. Res., 49, 268, 10.1002/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A Manoury-Schwartz, 1997, High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors, J. Immunol., 158, 5501, 10.4049/jimmunol.158.11.5501 Marazuela, 1997, Up-regulated β1-integrin expression in autoimmune thyroid disorders, Clin. Exp. Immunol., 109, 107, 10.1046/j.1365-2249.1997.4171323.x Mathisen, 1997, Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells, J. Exp. Med., 186, 159, 10.1084/jem.186.1.159 Mauri, 1996, Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis, Eur. J. Immunol., 26, 1511, 10.1002/eji.1830260716 Mauritz, 1988, Treatment with γ-interferon triggers the onset of collagen arthritis in mice, Arthritis Rheum., 31, 1297, 10.1002/art.1780311012 Mc Innes, 1996, The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis, Nat. Med., 2, 175, 10.1038/nm0296-175 Mc Innes, 1997, Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis, Nat. Med., 3, 189, 10.1038/nm0297-189 Mc Innes, 1998, Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis, Immunol. Today, 19, 75, 10.1016/S0167-5699(97)01205-X Mc Intyre, 1996, Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice, Eur. J. Immunol., 26, 2933, 10.1002/eji.1830261219 Merrill, 1992, Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10. PL mice, 89, 574 Mignon-Godefroy, 1995, Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglo-bulin-primed cells in ≪transfer-experimental autoimmune thyroiditis≫, Cell Immunol., 162, 171, 10.1006/cimm.1995.1066 Mignon-Godefroy, 1995, Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (TAE). Evidence for IL-10-enhanced cell death in TAE, J. Immunol., 154, 6634, 10.4049/jimmunol.154.12.6634 Moreland, 1997, Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75) -Fc fusion protein, N. Engl. J. Med., 337, 141, 10.1056/NEJM199707173370301 Moreland, 1996, Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis, J. Rheumatol., 23, 1849 Mori, 1996, Attenuation of collageninduced arthritis in 55-kDa TNF receptor type 1 (TNFR1) -IgG1-treated and TNFR1-deficient mice, J. Immunol., 157, 3178, 10.4049/jimmunol.157.7.3178 Moritani, 1994, Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice, Int. Immunol., 6, 1927, 10.1093/intimm/6.12.1927 Mosmann, 1996, The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol. Today, 17, 138, 10.1016/0167-5699(96)80606-2 Mueller, 1996, Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice, J. Exp. Med., 184, 1093, 10.1084/jem.184.3.1093 Nakajima, 1990, The effect of treatment with interferon-γ on type II collagen-induced arthritis, Clin. Exp. Immunol., 81, 441, 10.1111/j.1365-2249.1990.tb05353.x Nakamura, 1994, The role of TNF-α in the induction of experimental autoimmune uveoretinitis in mice, Invest. Ophthalmol. Vis. Sci., 35, 3884 Nepom, 1989, Determinants of genetic susceptibility in HLA-associated auto-immune disease, Clin. Immunol. Immunopathol., 53, S53, 10.1016/0090-1229(89)90070-6 Netea, 1997, Interleukin 1β, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals, Cytokine, 9, 284, 10.1006/cyto.1996.0165 Nicoletti, 1998, Paradoxical anti-diabetogenic effect of gamma-interferon in DP-BB rats, Diabetes, 47, 32, 10.2337/diabetes.47.1.32 Nicoletti, 1997, Prevention of spontaneous autoimmune diabetes in diabetesprone BB rats by prophylactic treat-ment with anti-rat interferon-gamma antibody, Endocrinology, 138, 281, 10.1210/en.138.1.281 O'Hara, 1996, Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice, Ann. N. Y. Acad. Sci., 795, 241, 10.1111/j.1749-6632.1996.tb52673.x Pakala, 1997, T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice, J. Exp. Med., 186, 299, 10.1084/jem.186.2.299 Panitch, 1987, Exacerbations of multiple sclerosis in patients treated with γ-interferon, Lancet, 1, 893, 10.1016/S0140-6736(87)92863-7 Pennline, 1994, Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse, Clin. Immunol. Immunopathol., 71, 169, 10.1006/clin.1994.1068 Picarella, 1993, Transgenic tumor necrosis factor (TNF) -alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-α and TNF-β transgenic mice, J. Immunol., 150, 4136, 10.4049/jimmunol.150.9.4136 Probert, 1995, The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice, Eur. J. Immunol., 25, 1794, 10.1002/eji.1830250647 Pujol-Borrell, 1983, Lectin-induced expression of DR antigen on human cultured follicular thyroid cells, Nature, 304, 71, 10.1038/304071a0 Rabinovitch, 1994, Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?, Diabetes, 43, 613, 10.2337/diabetes.43.5.613 Racke, 1991, Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transfor-ming growth factor-beta 1, J. Immunol., 146, 3012, 10.4049/jimmunol.146.9.3012 Racke, 1993, Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β 2, J. Neuroimmunol., 46, 175, 10.1016/0165-5728(93)90247-V Raine, 1995, Multiple sclerosis: TNF revisited, with promise, Nat. Med., 1, 244, 10.1038/nm0395-211 Ramanathan, 1996, Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats, J. Immunol., 157, 2209, 10.4049/jimmunol.157.5.2209 Rapoport, 1993, Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, J. Exp. Med., 178, 87, 10.1084/jem.178.1.87 Raziuddin, 1998, A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function, Clin. Immunol. Immunopathol., 86, 192, 10.1006/clin.1997.4457 Reimers, 1994, Interleukin-1 beta (IL-1) does not reduce the diabetes incidence in diabetes-prone BB rats, Autoimmunity, 17, 105, 10.3109/08916939409014665 Remy, 1987, Experimental autoimmune thyroiditis induced by recombinant interferon-gamma, Immunol Today, 8 Remy, 1986, Syngeneic sensitization of mouse lymphocytes on monolayers of thy-roid epithelial cells. IX. Thyroid epi-thelial cells are antigen presenting cells, Mol. Biol. Med., 3, 167 Renno, 1995, TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines, J. Immunol., 154, 944, 10.4049/jimmunol.154.2.944 Rizzo, 1996, Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10. A mice, J. Immunol., 156, 1654, 10.4049/jimmunol.156.4.1654 Rodriguez, 1995, Gamma Interferon is critical for resistance to Theiler's virus-induced demyelination, J. Virol., 69, 7286, 10.1128/JVI.69.11.7286-7290.1995 Rosenbaum, 1995, Paradoxical effects of IL-10 in endotoxin-induced uveitis, J. Immunol., 155, 4090, 10.4049/jimmunol.155.8.4090 Rothe, 1996, Interleukin-12 gene expression mediates the accelerating effect of cyclophosphamide in autoimmune disease, Ann. N. Y. Acad. Sci., 795, 397, 10.1111/j.1749-6632.1996.tb52704.x Rothe, 1997, Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (ID-12 antagonist IL-12 (p40) 2, Diabetologia, 40, 641, 10.1007/s001250050728 Rott, 1993, Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats, Eur. J. Immunol., 23, 1745, 10.1002/eji.1830230802 Rott, 1994, Interleukin-10 prevents experimental allergic encephalomyelitis in rats, Eur. J. Immunol., 24, 1434, 10.1002/eji.1830240629 Roura-Mir, 1997, Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease, Eur. J. Immunol., 27, 3290, 10.1002/eji.1830271228 Roux-Lombard, 1992, Inhibitors of interleukin-1 activity in synovial fluids and in cultured synovial fluid mononuclear cells, J. Rheumatol., 19, 517 Ruddle, 1990, An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis, J. Exp. Med., 172, 1193, 10.1084/jem.172.4.1193 Santambrogio, 1993, Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. Antagonism between TGF-β and tumor necrosis factor, J. Immunol., 151, 1116, 10.4049/jimmunol.151.2.1116 Sartani, 1996, Anti-TNF-α therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming, Invest. Ophthalmol. Vis. Sci., 37, 2211 Sarvetnick, 1988, Insul-independent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma, Cell, 52, 773, 10.1016/0092-8674(88)90414-X Sarvetnick, 1990, Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-γ, Nature, 346, 844, 10.1038/346844a0 Satoh, 1990, Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha, J. Immunol., 145, 1395, 10.4049/jimmunol.145.5.1395 Schirmbeck, 1994, Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo, Eur. J. Immunol., 24, 2068, 10.1002/eji.1830240920 Segal, 1998, An interleukin IL-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease, J. Exp. Med., 187, 537, 10.1084/jem.187.4.537 Selmaj, 1991, Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin, J. Immunol., 147, 1522, 10.4049/jimmunol.147.5.1522 Sethna, 1991, Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma, J. Neuroimmunol., 34, 121, 10.1016/0165-5728(91)90121-M Sharief, 1991, Association between tumor necrosis factoralpha and disease progression in patients with multiple sclerosis, N. Engl. J. Med., 325, 467, 10.1056/NEJM199108153250704 Shaw, 1997, Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis, J. Exp. Med., 185, 1711, 10.1084/jem.185.9.1711 Silver, 1995, Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype, Invest. Ophthalmol. Vis. Sci., 36, 946 Smith, 1997, Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat, Am. J. Pathol., 150, 1909 Sommer, 1995, The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis, Nat. Med., 1, 244, 10.1038/nm0395-244 Sospedra, 1995, Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?, J. Immunol., 154, 4213, 10.4049/jimmunol.154.8.4213 Speidel, 1997, Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency and relation to antibody responses, Eur. J. Immunol., 27, 2391, 10.1002/eji.1830270938 Stasiuk, 1996, Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen, Cell Immunol., 173, 269, 10.1006/cimm.1996.0277 Stevens, 1994, Transforming growth factor-β1 inhibits tumor necrosis factor-α/ Lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis, J. Neuroimmunol., 51, 77, 10.1016/0165-5728(94)90131-7 Stull, 1992, Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody, J. Immunol., 149, 2219, 10.4049/jimmunol.149.6.2219 Sugihara, 1995, Self-thyroid epithelial cell (TEC) -reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC, J. Immunol., 155, 1619, 10.4049/jimmunol.155.3.1619 Tandon, 1992, The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells, Clin. Immunol. Immunopathol., 64, 30, 10.1016/0090-1229(92)90056-T Tang, 1997, Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines, Int. Immunol., 9, 679, 10.1093/intimm/9.5.679 Tang, 1993, The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (TAE): prevention of disease and decrease of TAE-specific T cells, Eur. J. Immunol., 23, 275, 10.1002/eji.1830230143 Tang, 1998, Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice, J. Immunol., 160, 155, 10.4049/jimmunol.160.1.155 Texier, 1992, Characterization and sequencing of a 40-amino-acid peptide from human thyroglobulin inducing experimental autoimmune thyroiditis, J. Immunol., 148, 3405, 10.4049/jimmunol.148.11.3405 Todd, 1985, Interferon-γ induces HLA-DR expression by thyroid epithelium, Clin. Exp. Immunol., 61, 265 Todd, 1987, Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone, Clin. Exp. Immunol., 69, 524 Tominaga, 1998, Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice, Clin. Immunol. Immunopathol., 86, 209, 10.1006/clin.1997.4471 Trembleau, 1995, Inter leukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice, J. Exp. Med., 181, 817, 10.1084/jem.181.2.817 Trembleau, 1997, Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes, Eur. J. Immunol., 27, 2330, 10.1002/eji.1830270930 Vladutiu, 1971, Autoimmune murine thyroiditis. Relation to histocompatibility (H2) type, Science, 174, 1137, 10.1126/science.174.4014.1137 Walmsley, 1996, Interleukin-10 inhibition of the progression of established collagen-induced arthritis, Arthritis Rheum., 39, 495, 10.1002/art.1780390318 Weetman, 1990, Regulation of interleukin-6 release by human thyrocytes, J. Endocrinol., 127, 357, 10.1677/joe.0.1270357 Weetman, 1990, Functional analysis of intercellular adhesion molecule-1-expressing human thyroid cells, Eur. J. Immunol., 20, 271, 10.1002/eji.1830200207 Whitcup, 1996, IL-12 inhibits endotoxin-induced inflammation in the eye, Eur. J. Immunol., 26, 995, 10.1002/eji.1830260506 Wick, 1989, The obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis, Adv. Immunol., 47, 433, 10.1016/S0065-2776(08)60666-5 Wiesenberg, 1989, Suppression and augmentation of rat adju-vant arthritis with monoclonal antiinterferon-gamma antibody, Clin. Exp. Immunol., 78, 245 Williams, 1992, Anti-tumor necrosis factor ameliorates joint disease in murine colla-gen-induced arthritis, 89, 9784 Wogensen, 1993, Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans, J. Exp. Med., 178, 175, 10.1084/jem.178.1.175 Wong, 1996, CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells, J. Exp. Med., 183, 67, 10.1084/jem.183.1.67 Wooley, 1993, Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice, J. Immunol., 151, 6602, 10.4049/jimmunol.151.11.6602 Xu, 1997, Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis, Cell Immunol., 178, 69, 10.1006/cimm.1997.1121 Yokoi, 1997, Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12, Eur. J. Immunol., 27, 641, 10.1002/eji.1830270310 Yoshida, 1994, Interleukin-1 alpha interleukin-1b, and tumor necrosis factor gene expression in endotoxin-induced uveitis, Invest. Ophthalmol. Vis. Sci., 35, 1107 Zhao, 1995, Impact of interferon-γ receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis, J. Immunol., 155, 5736, 10.4049/jimmunol.155.12.5736 Zheng, 1990, Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves'and Hashimoto's diseases, J. Autoimmun., 3, 727, 10.1016/S0896-8411(05)80039-3 Zipris, 1996, Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats, J. Immunol., 156, 1315, 10.4049/jimmunol.156.3.1315